140 related articles for article (PubMed ID: 1494788)
1. Monoclonal antibodies in human organ transplantation and auto-immune diseases.
Wijdenes J; Roy C; Morel-Fourrier B; Racadot E
Therapie; 1992; 47(4):283-7. PubMed ID: 1494788
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppression with monoclonal antibodies in multiple sclerosis.
Hafler DA; Weiner HL
Neurology; 1988 Jul; 38(7 Suppl 2):42-7. PubMed ID: 3260356
[TBL] [Abstract][Full Text] [Related]
3. Failure of anti-T cell monoclonal antibodies to prevent acute tumor allograft rejection is associated with their inability to deplete or inactivate T cells at the site of rejection.
Rakhmilevich AL
Transplantation; 1994 Jul; 58(1):72-80. PubMed ID: 7913562
[TBL] [Abstract][Full Text] [Related]
4. Transplantation tolerance with monoclonal antibodies.
Wood KJ
Semin Immunol; 1990 Nov; 2(6):389-99. PubMed ID: 2104277
[TBL] [Abstract][Full Text] [Related]
5. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
[TBL] [Abstract][Full Text] [Related]
6. An anti-murine CD3 monoclonal antibody with a low affinity for Fc gamma receptors suppresses transplantation responses while minimizing acute toxicity and immunogenicity.
Alegre ML; Tso JY; Sattar HA; Smith J; Desalle F; Cole M; Bluestone JA
J Immunol; 1995 Aug; 155(3):1544-55. PubMed ID: 7636216
[TBL] [Abstract][Full Text] [Related]
7. Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice.
Hori J; Isobe M; Yamagami S; Mizuochi T; Tsuru T
Exp Eye Res; 1997 Jul; 65(1):89-98. PubMed ID: 9237869
[TBL] [Abstract][Full Text] [Related]
8. Bidirectional blockade of CD4 and major histocompatibility complex class II molecules: an effective immunosuppressive treatment in the mouse heart transplantation model.
Ito H; Hamano K; Fukumoto T; Wood KJ; Esato K
J Heart Lung Transplant; 1998 May; 17(5):460-9. PubMed ID: 9628564
[TBL] [Abstract][Full Text] [Related]
9. Anti-CD3 monoclonal antibody therapy. An approach toward optimization by in vitro analysis of new anti-CD3 antibodies.
Woodle ES; Thistlethwaite JR; Jolliffe LK; Fucello AJ; Stuart FP; Bluestone JA
Transplantation; 1991 Aug; 52(2):361-8. PubMed ID: 1714644
[TBL] [Abstract][Full Text] [Related]
10. [Interleukin 10 in disseminated lupus erythematosus].
Emilie D
J Soc Biol; 2002; 196(1):19-21. PubMed ID: 12134628
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic applications of anti-CD4 antibodies.
Olive D; Mawas C
Crit Rev Ther Drug Carrier Syst; 1993; 10(1):29-63. PubMed ID: 8472311
[TBL] [Abstract][Full Text] [Related]
12. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes.
Tsuchida M; Brown SA; Tutt LM; Tan J; Seehafer DL; Harris JP; Xun CQ; Thompson JS
Clin Transplant; 1997 Oct; 11(5 Pt 2):522-8. PubMed ID: 9361954
[TBL] [Abstract][Full Text] [Related]
13. Helplessness as a strategy for avoiding antiglobulin responses to therapeutic monoclonal antibodies.
Isaacs JD; Waldmann H
Ther Immunol; 1994 Dec; 1(6):303-12. PubMed ID: 7584505
[TBL] [Abstract][Full Text] [Related]
14. Porcine humoral immune responses to multiple injections of murine monoclonal antibodies.
Lohse L; Nielsen J; Kamstrup S; Oleksiewicz MB; Eriksen L
APMIS; 2005; 113(7-8):489-96. PubMed ID: 16086818
[TBL] [Abstract][Full Text] [Related]
15. New immunosuppressive therapies in renal transplantation: monoclonal antibodies.
Buhaescu I; Segall L; Goldsmith D; Covic A
J Nephrol; 2005; 18(5):529-36. PubMed ID: 16299678
[TBL] [Abstract][Full Text] [Related]
16. Specificity of monoclonal anti-nucleosome auto-antibodies derived from lupus mice.
Kramers K; Stemmer C; Monestier M; van Bruggen MC; Rijke-Schilder TP; Hylkema MN; Smeenk RJ; Muller S; Berden JH
J Autoimmun; 1996 Dec; 9(6):723-9. PubMed ID: 9115574
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of allograft rejection by anti-T-cell receptor-alpha beta monoclonal antibodies preserving resistance to bacterial infection.
Eto M; Yoshikai Y; Nishimura Y; Hiromatsu K; Maeda T; Nomoto K; Kong YY; Kubo RT; Kumazawa J; Nomoto K
Immunology; 1994 Feb; 81(2):198-204. PubMed ID: 8157269
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of transplant rejection by pretreatment of xenogeneic pancreatic islet cells with anti-ICAM-1 antibodies.
Zeng Y; Gage A; Montag A; Rothlein R; Thistlethwaite JR; Bluestone JA
Transplantation; 1994 Sep; 58(6):681-9. PubMed ID: 7940687
[TBL] [Abstract][Full Text] [Related]
19. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibody treatment of human allograft recipients.
Delmonico FL; Cosimi AB
Surg Gynecol Obstet; 1988 Jan; 166(1):89-98. PubMed ID: 3276014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
